vTv Therapeutics Inc.

02/17/2021 | Press release | Distributed by Public on 02/17/2021 15:11

vTv Therapeutics Announces Initiation of Multiple Ascending Dose Study of HPP737, an Oral PDE4 Inhibitor for the Treatment of Psoriasis